

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in managing and understanding... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-280/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-280" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in managing and understanding uveitis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in managing and understanding uveitis.">
            <meta name="og:description" content="Read the latest article version by Shih-Chou Chen, Shwu-Jiuan Sheu, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11409">
            <meta name="article-id" content="10587">
            <meta name="dc.title" content="Recent advances in managing and understanding uveitis">
            <meta name="dc.description" content="Uveitis is a sight-threatening disease entity with intraocular inflammation that arises from various causes. It mainly affects working-age individuals and may lead to irreversible visual loss if not treated properly in a timely manner. This article reviews recent advances in the management and understanding of uveitis since 2014, including treatment with new immunosuppressive therapies that use biological agents, local therapy with steroid implants, and imaging studies for the evaluation of uveitis.">
            <meta name="dc.subject" content="immunosuppressive therapy, ocular implants, optical coherence tomography (OCT), uveitis">
            <meta name="dc.creator" content="Chen, Shih-Chou">
            <meta name="dc.creator" content="Sheu, Shwu-Jiuan">
            <meta name="dc.date" content="2017/03/16">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10587.1">
            <meta name="dc.source" content="F1000Research 2017 6:280">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="immunosuppressive therapy ">
            <meta name="prism.keyword" content=" ocular implants ">
            <meta name="prism.keyword" content=" optical coherence tomography (OCT) ">
            <meta name="prism.keyword" content=" uveitis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/03/16">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="280">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10587.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-280">
            <meta name="citation_title" content="Recent advances in managing and understanding uveitis">
            <meta name="citation_abstract" content="Uveitis is a sight-threatening disease entity with intraocular inflammation that arises from various causes. It mainly affects working-age individuals and may lead to irreversible visual loss if not treated properly in a timely manner. This article reviews recent advances in the management and understanding of uveitis since 2014, including treatment with new immunosuppressive therapies that use biological agents, local therapy with steroid implants, and imaging studies for the evaluation of uveitis.">
            <meta name="citation_description" content="Uveitis is a sight-threatening disease entity with intraocular inflammation that arises from various causes. It mainly affects working-age individuals and may lead to irreversible visual loss if not treated properly in a timely manner. This article reviews recent advances in the management and understanding of uveitis since 2014, including treatment with new immunosuppressive therapies that use biological agents, local therapy with steroid implants, and imaging studies for the evaluation of uveitis.">
            <meta name="citation_keywords" content="immunosuppressive therapy, ocular implants, optical coherence tomography (OCT), uveitis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Shih-Chou Chen">
            <meta name="citation_author_institution" content="Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan">
            <meta name="citation_author" content="Shwu-Jiuan Sheu">
            <meta name="citation_author_institution" content="Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan">
            <meta name="citation_author_institution" content="School of Medicine, National Yang-Ming University, Taipei, Taiwan">
            <meta name="citation_publication_date" content="2017/03/16">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="280">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10587.1">
            <meta name="citation_firstpage" content="280">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-280/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-280.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11409 /> <input type=hidden id=articleId name=articleId value=10587 /> <input type=hidden id=xmlUrl value="/articles/6-280/v1/xml"/> <input type=hidden id=xmlFileName value="-6-280-v1.xml"> <input type=hidden id=article_uuid value=a1134dfe-f7d7-4836-a99f-47ebaa864b51 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in managing and understanding uveitis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10587.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10587.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-280"
  },
  "headline": "Recent advances in managing and understanding uveitis",
  "datePublished": "2017-03-16T11:36:46",
  "dateModified": "2017-03-16T11:36:46",
  "author": [
    {
      "@type": "Person",
      "name": "Shih-Chou Chen"
    },    {
      "@type": "Person",
      "name": "Shwu-Jiuan Sheu"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Uveitis is a sight-threatening disease entity with intraocular inflammation that arises from various causes. It mainly affects working-age individuals and may lead to irreversible visual loss if not treated properly in a timely manner. This article reviews recent advances in the management and understanding of uveitis since 2014, including treatment with new immunosuppressive therapies that use biological agents, local therapy with steroid implants, and imaging studies for the evaluation of uveitis."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-280",
            "name": "Recent advances in managing and understanding uveitis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in managing and understanding uveitis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11409 data-id=10587 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10587.1" data-recommended="" data-doi="10.12688/f1000research.10587.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-280/v1/pdf?article_uuid=a1134dfe-f7d7-4836-a99f-47ebaa864b51" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10587-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10587-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10587-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Chen SC and Sheu SJ. Recent advances in managing and understanding uveitis [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):280 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10587.1" target=_blank>https://doi.org/10.12688/f1000research.10587.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10587-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10587 id=track-article-signin-10587 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10587?target=/articles/6-280">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11409 /> <input name=articleId type=hidden value=10587 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in managing and understanding uveitis</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Shih-Chou Chen<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:sjsheu@isca.vghks.gov.tw" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Shwu-Jiuan Sheu</span></a><a href="https://orcid.org/0000-0003-2644-2475" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2644-2475</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Shih-Chou Chen<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:sjsheu@isca.vghks.gov.tw" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Shwu-Jiuan Sheu</span></a><a href="http://orcid.org/0000-0003-2644-2475" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2644-2475</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 16 Mar 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10587.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan<br/> <sup>2</sup> School of Medicine, National Yang-Ming University, Taipei, Taiwan<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21075-20793></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21073-20795></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21077-20796></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Uveitis is a sight-threatening disease entity with intraocular inflammation that arises from various causes. It mainly affects working-age individuals and may lead to irreversible visual loss if not treated properly in a timely manner. This article reviews recent advances in the management and understanding of uveitis since 2014, including treatment with new immunosuppressive therapies that use biological agents, local therapy with steroid implants, and imaging studies for the evaluation of uveitis. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> immunosuppressive therapy, ocular implants, optical coherence tomography (OCT), uveitis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Shwu-Jiuan Sheu (<a href="mailto:sjsheu@isca.vghks.gov.tw">sjsheu@isca.vghks.gov.tw</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Shwu-Jiuan Sheu </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of the article. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Chen SC and Sheu SJ. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Chen SC and Sheu SJ. Recent advances in managing and understanding uveitis [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):280 (<a href="https://doi.org/10.12688/f1000research.10587.1" target=_blank>https://doi.org/10.12688/f1000research.10587.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 16 Mar 2017, <b>6</b>(F1000 Faculty Rev):280 (<a href="https://doi.org/10.12688/f1000research.10587.1" target=_blank>https://doi.org/10.12688/f1000research.10587.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 16 Mar 2017, <b>6</b>(F1000 Faculty Rev):280 (<a href="https://doi.org/10.12688/f1000research.10587.1" target=_blank>https://doi.org/10.12688/f1000research.10587.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d69982e164>Introduction</h2><p class="" id=d69982e167>Uveitis is a sight-threatening disease entity with intraocular inflammation that arises from various causes. It may lead to irreversible visual loss if not treated properly in a timely manner. As many as 35% of patients with uveitis exhibit blindness or visual impairment in at least one eye<sup><a href="#ref-1">1</a></sup>. Uveitis is the fifth most common cause of severe visual loss in the developed world, and up to 20% of legal blindness is due to complications of uveitis<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>.</p><p class="" id=d69982e181>On the basis of etiology, uveitis can be divided into infectious uveitis and non-infectious uveitis. In infectious uveitis, treatments are aimed mainly at the pathogens. In non-infectious uveitis, systemic corticosteroids are the most widespread treatment regimen. Because of the undesirable side effects and restricted function of systemic corticosteroids, the use of immunosuppressants and local therapy with steroid implants has become more popular in recent years.</p><p class="" id=d69982e184>Many advances have been made in the management and understanding of uveitis in the 3 years between 2014 and 2016. In this review, we briefly discuss uveitis treatment with new immunosuppressive therapies based on biological agents and local therapy with steroid implants; many of these novel approaches are currently being evaluated in clinical trials. New progress in imaging studies for the evaluation of uveitis, including enhanced depth imaging (EDI), optical coherence tomography (OCT), and ultra-wide-field fluorescein angiography, will also be discussed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d69982e190>Biological agents</h2><p class="" id=d69982e193>Advances in molecular research have confirmed that the dysregulation of inflammatory cytokines plays an important role in the pathogenesis of immune-mediated disease and have allowed the development of new targeted therapies that interfere with specific molecules that cause inflammation and tissue damage<sup><a href="#ref-4">4</a></sup>. New targeted therapies or biological agents are widely used in rheumatology and, in recent years, have been introduced into the management of refractory uveitis. Biological agents, including cytokine inhibitors, monoclonal antibodies, and growth factor inhibitors, have been made using recombinant DNA technology. Many clinical studies about the development and outcome of new biological agents for uveitis treatment have been published in recent years. In addition, various types of intravitreal injections have been tried, and the results have been published. Targeted delivery of therapeutic agents is expected to decrease the need for systemic therapy, and to reduce the associated side effects, but not to replace systemic treatment.</p><div class=section><a name=d69982e200 class=n-a></a><h3 class=section-title>Adalimumab</h3><p class="" id=d69982e205>Adalimumab is a human antitumor necrosis factor-alpha (antiTNF-) monoclonal antibody. It was the first fully human monoclonal antibody drug approved by the US Food and Drug Administration (FDA). Adalimumab and infliximab were the best-studied antiTNF agents in ophthalmology and indeed have now been recommended by an expert panel for first-line treatment of ocular manifestations of Behets disease and second-line treatment of other forms of uveitis<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>.</p><p class="" id=d69982e215>Several studies about adalimumab in the treatment of uveitis were published recently. For example, Jaffe <i>et al.</i> conducted a multinational phase 3 trial that involved 217 patients who had active non-infectious intermediate uveitis, posterior uveitis, or panuveitis<sup><a href="#ref-7">7</a></sup>. Patients were randomly assigned to receive adalimumab or matched placebo. Outcomes regarding change in anterior chamber cell grade, vitreous haze grade, and best corrected visual acuity (BCVA) were significantly better in the adalimumab group than in the placebo group. However, adverse events and serious adverse events were reported more frequently among patients who received adalimumab. Van Denderen <i>et al.</i> demonstrated the effect of systemic adalimumab in treating acute uveitis secondary to ankylosing spondylitis in 77 patients<sup><a href="#ref-8">8</a></sup>. A significant reduction in the number of anterior uveitis attacks per patient was observed during adalimumab treatment.</p><p class="" id=d69982e232>Cordero-Coma <i>et al.</i> evaluated the immunogenicity induced by adalimumab on the basis of drug serum level and clinical responses in 25 patients with non-infectious uveitis who were resistant to conventional therapy<sup><a href="#ref-9">9</a></sup>. Median trough adalimumab serum levels were higher in responders than in non-responders. Development of permanent antibodies against adalimumab was associated with undetectable trough adalimumab levels and worse uveitis outcomes in non-responders. The short-term efficacy of intravitreal adalimumab (IVA) for the treatment of eyes with active non-infectious uveitis was reported by Hamam <i>et al.</i><sup><a href="#ref-10">10</a></sup>. Six patients (12 eyes) completed 26 weeks of IVA treatment. Seven eyes had improvement of at least two Early Treatment Diabetic Retinopathy Study (ETDRS) lines, nine out of ten eyes with vitreous haze had no haze at 26 weeks, and five out of eight eyes with macular edema had complete resolution. IVA was effective in controlling inflammation, decreasing macular edema, and improving BCVA in the majority of eyes in this series.</p></div><div class=section><a name=d69982e249 class=n-a></a><h3 class=section-title>Infliximab</h3><p class="" id=d69982e254>Infliximab is a chimeric antiTNF- monoclonal antibody used to treat autoimmune diseases. An expert panel also recommended infliximab as a first-line treatment of ocular manifestations of Behets disease and second-line treatment for other forms of uveitis<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>.</p><p class="" id=d69982e264>The efficacy of adalimumab and infliximab in refractory uveitis due to Behets disease was described by Calvo-Ro <i>et al.</i><sup><a href="#ref-11">11</a></sup>. In 124 patients with Behets disease uveitis refractory to conventional treatment, including high-dose corticosteroids and at least one standard immunosuppressive agent, 77 patients received infliximab and 47 patients received adalimumab. In the majority of patients, a decrease in anterior chamber and vitreous inflammation, a reduction in macular thickness, and improvements in BCVA were observed.</p><p class="" id=d69982e273>Takeuchi <i>et al.</i> conducted a multicenter study to evaluate the long-term efficacy and safety of infliximab treatment in 164 Behets disease patients with uveitis<sup><a href="#ref-12">12</a></sup>. Infliximab reduced the frequency of ocular attacks, improved visual acuity, and was generally well tolerated with few serious adverse events. Approximately 80% of relapses occurred within 1 year after the initiation of infliximab treatment, and 90% of these relapses were controlled by increasing doses of topical corticosteroids and shortening the interval between infliximab infusions.</p><p class="" id=d69982e283>Kruh <i>et al.</i> conducted a retrospective chart review to analyze the safety and efficacy of infliximab for the treatment of refractory non-infectious uveitis<sup><a href="#ref-13">13</a></sup>. Of the 88 patients with chronic and recalcitrant uveitis treated with infliximab, 72 patients (81.8%) achieved clinical remission. Thirty-two patients (36.4%) experienced at least one side effect, and 17 patients (19.3%) discontinued treatment because of intolerable side effects. The most common adverse effects were skin rash (9.1%) and fatigue (8%). Infliximab induces a high rate of complete clinical remission in recalcitrant uveitis and is well tolerated by most patients.</p></div><div class=section><a name=d69982e294 class=n-a></a><h3 class=section-title>Etanercept</h3><p class="" id=d69982e299>Etanercept is a fusion protein that acts as a TNF inhibitor and is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis (JIA), psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis. Saeed <i>et al.</i> reported about five patients with JIA-related uveitis who previously received methotrexate but had suboptimal responses in controlling uveitis and were switched to etanercept treatment<sup><a href="#ref-14">14</a></sup>. Three out of five patients did not show any signs of uveitis at their last follow-up. Etanercept may be useful in controlling JIA-related uveitis or arthritis in pediatric patients when methotrexate has had a suboptimal effect in controlling the inflammatory activity. Most experts will agree that etanercept is not a good option for the management of uveitis but is a good option for arthritis. There are a few reports linking this agent to inducing episodes of uveitis.</p></div><div class=section><a name=d69982e311 class=n-a></a><h3 class=section-title>Golimumab</h3><p class="" id=d69982e316>Golimumab is a human IgG1 TNF- antagonist monoclonal antibody and is approved by the FDA for once-monthly subcutaneous administration as a treatment for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The affinity of golimumab for soluble human TNF-, as determined by surface plasmon resonance, was similar to that of etanercept, greater than that of infliximab, and significantly greater than that of adalimumab<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d69982e323>Miserocchi <i>et al.</i> reported the long-term efficacy of subcutaneous injections of golimumab 50 mg monthly in 17 patients (34 eyes) with severe recalcitrant uveitis who had inadequate response to previous biologics<sup><a href="#ref-16">16</a></sup>. Of the 17 patients, 14 patients responded to golimumab. Visual acuity remained stable in 26 eyes, improved in 7, and worsened in 1. This study concluded that golimumab may be a promising new therapeutic option for severe uveitis patients who have not responded to other biologics. Similar results were reported in 3 patients with non-infectious uveitis that was refractory to standard immunosuppressive drugs and had previously been treated with other antiTNF- drugs<sup><a href="#ref-17">17</a></sup>.</p></div><div class=section><a name=d69982e338 class=n-a></a><h3 class=section-title>Secukinumab</h3><p class="" id=d69982e343>Secukinumab is a fully human antiinterleukin-17A monoclonal antibody that has been approved by the FDA for the treatment of ankylosing spondylitis and psoriatic arthritis. Letko <i>et al.</i> conducted a multicenter randomized clinical trial to evaluate the efficacy and safety of secukinumab in 37 patients with non-infectious uveitis<sup><a href="#ref-18">18</a></sup>. Intravenous 30 mg/kg secukinumab produced higher response rates (72.7% versus 33.3%) and remission rates (27.3% versus 16.7%) compared with subcutaneous 300 mg secukinumab<sup><a href="#ref-18">18</a></sup>. Intravenous secukinumab was effective and well tolerated in non-infectious uveitis that required systemic corticosteroid-sparing immunosuppressive therapy. High-dose intravenous secukinumab may be necessary to deliver secukinumab in therapeutic concentrations.</p></div><div class=section><a name=d69982e358 class=n-a></a><h3 class=section-title>Tocilizumab</h3><p class="" id=d69982e363>Tocilizumab is a humanized monoclonal antibody against the interleukin-6 receptor and is used mainly for the treatment of rheumatoid arthritis and JIA. Papo <i>et al.</i> observed eight patients with severe and refractory non-infectious uveitis treated with tocilizumab 8 mg/kg every 4 weeks intravenously<sup><a href="#ref-19">19</a></sup>. Seven patients had been previously treated with antiTNF- agents. The immunosuppressive drugs used in association with tocilizumab were azathioprine (n = 2), mycophenolate mofetil (n = 2), and methotrexate (n = 2). After a median follow-up of 8 months, six patients improved after tocilizumab treatment and two patients were non-responders. Visual acuity improved in five patients. The long-term effects of tocilizumab therapy for refractory uveitis-related macular edema was supported by a study by Mesquida <i>et al.</i><sup><a href="#ref-20">20</a></sup>. According to this case series, tocilizumab seems to be a safe and promising therapy in severe and refractory non-infectious uveitis.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d69982e383>Other immunosuppressive therapies</h2><div class=section><a name=d69982e386 class=n-a></a><h3 class=section-title>Sirolimus</h3><p class="" id=d69982e391>Sirolimus (previously known as rapamycin) is produced by a strain of <i>Streptomyces hygroscopicus</i>. Sirolimus is a potent inhibitor of the antigen-induced proliferation of T cells, B cells, and antibodies. Demonstration of the potent immunosuppressive activity of sirolimus in animal models of organ transplantation led to clinical trials and subsequent approval by the FDA for prophylaxis against renal graft rejection<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d69982e401>Early phase I/II studies have provided encouraging safety and efficacy data concerning the use of sirolimus to treat uveitis. Sirolimus appears to be an important addition to the armamentarium of steroid-sparing therapeutic agents that act on various steps in the inflammatory pathway<sup><a href="#ref-22">22</a></sup>. Phase III clinical trials are ongoing. Intravitreal sirolimus appears to be an interesting option for the treatment of non-infectious posterior uveitis because of its highly targeted molecular effects, non-steroidal nature, and good safety profile<sup><a href="#ref-23">23</a></sup>.</p></div><div class=section><a name=d69982e413 class=n-a></a><h3 class=section-title>Intravenous immunoglobulin therapy</h3><p class="" id=d69982e418>Intravenous immunoglobulin (IVIG) therapy involves the use of immunoglobulin mixtures. It has multiple mechanisms of immunomodulatory action and is used to treat various autoimmune, infectious, and idiopathic diseases. IVIG is approved for the treatment of autoimmune idiopathic thrombocytopenic purpura, allogeneic bone marrow transplantation, Kawasaki disease, and chronic lymphocytic leukemia.</p><p class="" id=d69982e421>According to a retrospective chart review of four patients with active non-infectious uveitis refractory to steroids and immunomodulatory therapy, three patients who received IVIG experienced disease stabilization and prevention of disease progression. But treatment failed to induce long-term remission in one patient who experienced a recurrence of macular edema<sup><a href="#ref-24">24</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d69982e432>Corticosteroid implants</h2><p class="" id=d69982e435>Corticosteroids are the first-line therapy in the treatment of most cases of uveitis. Topical corticosteroids are effective in the treatment of anterior uveitis but provide only poor response in intermediate uveitis, posterior uveitis, and panuveitis because of the drugs limited diffusion into target tissues. Periocular injection improves the drug delivery, but the outcome is still not satisfactory. Systemic administration of corticosteroids affords higher drug concentration but leads to undesirable side effects such as increased body weight, puffy face, gastric ulcers, hyperglycemia, hypertension, insomnia, osteoporosis, and growth retardation in children, among other undesirable effects.</p><p class="" id=d69982e438>Intravitreal triamcinolone had been used off-label for quite some time, and its effects on the control of inflammation and reduction of macular edema are well documented but entail significant side effects on intraocular pressure and cataract formation<sup><a href="#ref-25">25</a></sup>. Park <i>et al.</i> treated 49 eyes with intravitreal triamcinolone acetonide injection for refractory Behets posterior uveitis<sup><a href="#ref-26">26</a></sup>. The patients mean BCVA scores improved from 0.89 logMAR units to 0.70 and 0.64 at 12 and 24 months, respectively, and complete inflammation control was achieved in 87% of patients. But ocular complications, including cataract formation and elevated intraocular pressure, limit the efficacy and repeatability of this treatment.</p><p class="" id=d69982e452>Intravitreal injection of a slow-release corticosteroid implant offers better safety and efficacy for the treatment of non-infectious intermediate or posterior uveitis. Currently available steroid implants indicated for uveitis include Retisert (0.59 mg fluocinolone acetonide; Bausch &amp; Lomb, Rochester, NY, USA) and Ozurdex (700 g dexamethasone; Allergan, Irvine, CA, USA). In a phase III study (the Chronic Uveitis Evaluation of the Intravitreal Dexamethasone Implant (HURON<b>)</b> clinical trial), a single dexamethasone intravitreal implant significantly reduced intraocular inflammation and improved visual acuity for 6 months in patients with non-infectious intermediate or posterior uveitis. The incidence of elevated intraocular pressure and cataract formation did not differ significantly from that of the placebo group in this short-term study<sup><a href="#ref-27">27</a></sup>. In a multicenter study by Zarranz-Ventura <i>et al.</i>, Ozurdex implants were associated with favorable visual acuity and vitreous haze scores, but the treatment requires repeated injections<sup><a href="#ref-28">28</a></sup>. The cumulative effects in improving retinal thickness and resolving ocular inflammation were shown in a retrospective long-term series that also showed minimal complications<sup><a href="#ref-29">29</a></sup>. Complications included cataract progression and elevated intraocular pressure; the latter was mostly controllable by pressure-lowering agents. The reported complication rates were lower than those associated with Retisert or triamcinolone.</p><div class=section><a name=d69982e473 class=n-a></a><h3 class=section-title>Corticosteroid implants and pediatric uveitis</h3><p class="" id=d69982e478>Bratton <i>et al.</i> reported that dexamethasone implants, in combination with systemic immunomodulatory therapy, resulted in improved visual acuity, control of intraocular inflammation, and a decrease in corticosteroid use during the treatment of pediatric uveitis<sup><a href="#ref-30">30</a></sup>. The uveitis reoccurred in 57% of eyes at 4.3 months (range of 27 months) after injection. The adverse events were similar to those identified in adult studies. These effects were supported by other series that showed that repeated implantations resulted in continued control of the inflammation, allowing a reduction of systemic immunosuppression with few ocular complications<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>. However, more data are required to establish the long-term safety of the implants in the pediatric age group.</p></div><div class=section><a name=d69982e497 class=n-a></a><h3 class=section-title>Multicenter Uveitis Steroid Treatment trial</h3><p class="" id=d69982e502>The Multicenter Uveitis Steroid Treatment (MUST) trial identified 479 intermediate, posterior, and panuveitic eyes randomly assigned to either systemic immunosuppression or intravitreal fluocinolone acetonide implant therapy<sup><a href="#ref-33">33</a></sup>. Similarly favorable 2-year outcomes following both systemic treatment and fluocinolone acetonide implant treatment were found. Eyes that presented with more prolonged or severe inflammatory findings initially or during follow-up had a worse visual prognosis<sup><a href="#ref-33">33</a></sup>. The results at 54 months showed that visual outcomes after fluocinolone acetonide implant and systemic treatment for intermediate uveitis, posterior uveitis, and panuveitis were similar<sup><a href="#ref-34">34</a></sup>. For bilateral uveitis cases, systemic treatment may be necessary as the initial treatment on the basis of the cost-effectiveness. But steroid implant therapy can be considered in unilateral uveitis cases and when systemic treatment is not successful<sup><a href="#ref-34">34</a></sup>.</p><p class="" id=d69982e521>The risk and quality-of-life (QoL) analysis of the MUST trial at 54-month follow-up revealed an association between fluocinolone acetonide implant therapy and increased risk of glaucoma and cataracts. In self-reported QoL analysis, implant therapy was favored in initial time. But similar QoL results were disclosed between implant therapy and systemic therapy groups over time<sup><a href="#ref-35">35</a></sup>.</p></div><div class=section><a name=d69982e529 class=n-a></a><h3 class=section-title>Corticosteroid implants and Behets posterior uveitis</h3><p class="" id=d69982e534>Cokun <i>et al.</i> investigated 17 eyes of 12 patients with active Behets posterior uveitis that received a single intravitreal injection of a dexamethasone implant<sup><a href="#ref-36">36</a></sup>. The mean BCVA was significantly increased, the mean central macular thickness was significantly decreased, and the vitreous haze score was significantly decreased from baseline at each control visit at months 1, 3, 6, and 12. Three eyes showed spikes of intraocular pressure that required topical anti-glaucoma treatment<sup><a href="#ref-36">36</a></sup>.</p></div><div class=section><a name=d69982e549 class=n-a></a><h3 class=section-title>Review of corticosteroid implants</h3><p class="" id=d69982e554>Burkholder <i>et al.</i> conducted an anonymous online survey to describe the practice patterns and perceptions of uveitis specialists regarding the use of intravitreal dexamethasone implants for the treatment of non-infectious uveitis<sup><a href="#ref-37">37</a></sup>. The authors found no clear consensus on preferences regarding the use of dexamethasone versus fluocinolone acetonide implants.</p><p class="" id=d69982e564>Brady <i>et al.</i> conducted a search of the Cochrane database about the use of corticosteroid implants to treat chronic non-infectious uveitis<sup><a href="#ref-38">38</a></sup>. The study included randomized controlled trials comparing either fluocinolone acetonide or dexamethasone intravitreal implants versus standard-of-care therapy with at least 6 months of follow-up. Two studies compared fluocinolone acetonide implants with standard-of-care therapy and showed that fluocinolone acetonide implants probably prevent recurrence of uveitis compared with standard-of-care therapy (risk ratio of 0.29), but the implants were associated with increased risks of needing cataract surgery (risk ratio of 2.98) and surgery to lower intraocular pressure (risk ratio of 7.48). No studies have compared dexamethasone implants with standard-of-care therapy<sup><a href="#ref-38">38</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d69982e582>Imaging studies in uveitis</h2><div class=section><a name=d69982e585 class=n-a></a><h3 class=section-title>Enhanced depth imagingoptical coherence tomography in uveitis</h3><p class="" id=d69982e590>Enhanced depth imagingoptical coherence tomography (EDI-OCT) was able to image the choroid with reasonable clarity using commercial spectral-domain OCT and proved to be a promising novel technique for imaging the choroid<sup><a href="#ref-39">39</a></sup>. With the introduction of EDI, visualization of the choroid and choriocapillaris has become possible. Therefore, OCT has become an indispensable ancillary test in the diagnosis and management of inflammatory diseases involving the retina and choroid<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d69982e601>Yan <i>et al.</i> investigated the retinal and choroidal thickness in 148 eyes from 97 patients with inactive uveitis and 98 eyes from 55 normal patients using spectral-domain OCT with EDI of the retina and choroid<sup><a href="#ref-41">41</a></sup>. The mean subfoveal retinal thickness did not differ significantly between uveitis patients and controls. The mean choroidal thickness at multiple locations was significantly lower in uveitis patients compared with normal patients; this difference was most significant at the fovea. The choroidal thickness was reduced in patients with inactive uveitis and was associated with disease duration and frequency, although retinal thickness did not seem to be affected by disease processes.</p><p class="" id=d69982e611>Macular edema is a common cause of visual loss in patients with uveitis. Ghl <i>et al.</i> used spectral-domain OCT with EDI scans to evaluate the retinal and choroidal thickness of 21 patients with anterior uveitis, 23 patients with intermediate uveitis, and 34 age-matched healthy controls<sup><a href="#ref-42">42</a></sup>. The mean central retinal subfield thickness was significantly higher in the intermediate uveitis group but was not significantly different in the anterior uveitis group compared with the control group. The retina in both uveitis groups was significantly thicker in the 3- and 6-mm perifoveal rings than those in the control group, but no significant difference was found in central choroidal thickness.</p></div><div class=section><a name=d69982e622 class=n-a></a><h3 class=section-title>Anterior segmentoptical coherence tomography in uveitis</h3><p class="" id=d69982e627>Anterior segmentOCT (ASOCT) was developed specifically for imaging anterior segment structures. Sharma <i>et al.</i> designed an observational case series to determine the feasibility of ASOCT to objectively image and quantify the degree of anterior chamber inflammation in patients with uveitis<sup><a href="#ref-43">43</a></sup>. In the 76 patients with 114 eyes collected, 83 eyes were imaged with line scans and 31 eyes were imaged with volume scans. The number of cells detected with line scans and volume scans was correlated with clinical grading. Automated algorithm had a strong correlation with manual measurement when measuring cell counts in three-dimensional volume scans. ASOCT can be used to measure anterior chamber inflammation to identify responses to treatment in patients with uveitis<sup><a href="#ref-43">43</a></sup>.</p></div><div class=section><a name=d69982e642 class=n-a></a><h3 class=section-title>Evaluation of vitreous inflammation by optical coherence tomography</h3><p class="" id=d69982e647>OCT plays an important role in the evaluation of vitreous inflammation intensity. Keane <i>et al.</i> collected 30 eyes of 30 patients with vitreous haze secondary to intermediate, posterior, or panuveitis; 12 eyes of 12 patients with uveitis without vitreous haze; and 18 eyes of 18 patients without intraocular inflammation<sup><a href="#ref-44">44</a></sup>. The severity of vitreous haze was classified on the basis of the National Eye Institute system. Spectral-domain OCT was used to measure vitreous (VIT) signal intensity and compared with intensity of retinal pigment epithelium (RPE), generating a ratio of VIT/RPE-relative intensity. This ratio was significantly higher in uveitic eyes than in uveitic eyes without vitreous haze or in healthy controls. The VIT/RPE-relative intensity showed a significant, positive correlation with clinical vitreous haze scores<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d69982e661>The same result of significant positive correlation with vitreous haze score and VIT/RPE-relative intensity was demonstrated in a retrospective cohort study by Zarranz-Ventura <i>et al.</i> with 105 uveitic eyes of 105 patients, which remained significant after adjusting for factors affecting media clarity such as anterior chamber cells, flares, and phakic status<sup><a href="#ref-45">45</a></sup>. Sreekantam <i>et al.</i> also used spectral-domain OCT to evaluate the vitreous inflammation in patients with uveitic cystoid macular edema before and after sub-Tenons triamcinolone acetonide injection<sup><a href="#ref-46">46</a></sup>. Treatment with triamcinolone acetonide resulted in a significant reduction in VIT/RPE-relative intensity, central retinal thickness, and improvement in visual acuity. These results provide evidence that OCT is useful in measurements of vitreous intensity and outcome in patients with uveitis.</p></div><div class=section><a name=d69982e679 class=n-a></a><h3 class=section-title>Ultra-wide-field fluorescein angiography</h3><p class="" id=d69982e684>The peripheral retina is the site of pathology in many ocular diseases, and ultra-wide-field imaging is one of the new technologies available for ophthalmologists as they manage these diseases. With the advent of ultra-wide-field fluorescein angiography, it is now possible to view up to 200 of the retina in a single photograph measured from the ocular center<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d69982e691>Karampelas <i>et al.</i> investigated the relationships between peripheral vasculitis, ischemia, and vascular leakage in 82 uveitis patients by using ultra-wide-field fluorescein angiography<sup><a href="#ref-48">48</a></sup>. Although central leakage was associated with peripheral leakage, there was no association between foveal avascular zone size and peripheral ischemia. Peripheral ischemia correlated with neovascularization-related leakage and focal vasculitis. Only macular ischemia and increased macular thickness were independently associated with reduced visual acuity.</p><p class="" id=d69982e701>Chi <i>et al.</i> evaluated peripheral retinal vascular changes in anterior uveitis by using ultra-wide-field fluorescein angiography in 65 eyes of 33 patients with anterior uveitis<sup><a href="#ref-49">49</a></sup>. Peripheral vessel leakage was detected in 27 eyes (42%) with anterior uveitis, of which 15 eyes displayed active inflammation and 12 eyes displayed inactive inflammation. Peripheral vessel leakage was found in seven out of eight eyes with cystoid macular edema. The treatment strategies for these patients were modified on the basis of the results of ultra-wide-field fluorescein angiography<sup><a href="#ref-49">49</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d69982e720>Summary</h2><p class="" id=d69982e723>The diagnosis and treatment of uveitis have advanced markedly in recent years. We reviewed publications regarding the management and understanding of uveitis during the past three years, including biological agents, steroid implants, and imaging studies for the evaluation and treatment of uveitis. The progress in imaging techniques helps physicians understand the pathogenesis of uveitis and can also be used for the diagnosis and follow-up of disease activity or as a useful guide to treatment. Recent and ongoing studies are contributing to more focused treatments, including biologic agents and intraocular implants.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d69982e1 class=n-a></a><h2 class=main-title id=d70180>Competing interests</h2><p class=metadata-entry><a name=d69982e99 class=n-a></a><p id=d69982e101> The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of the article.</p></p></div><div class=back-section><a name=d69982e1 class=n-a></a><h2 class=main-title id=d70182>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d69982e730 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d70342>References</h2><div class="section ref-list"><a name=d69982e730 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d69982e737 class=n-a></a>Rothova A, Suttorp-van Schulten MS, Frits Treffers W, <i> et al.</i>: Causes and frequency of blindness in patients with intraocular inflammatory disease. <i>Br J Ophthalmol.</i> 1996; <b>80</b>(4): 3326. <a target=xrefwindow id=d69982e748 href="http://www.ncbi.nlm.nih.gov/pubmed/8703885">PubMed Abstract </a> | <a target=xrefwindow id=d69982e751 href="http://dx.doi.org/10.1136/bjo.80.4.332">Publisher Full Text </a> | <a target=xrefwindow id=d69982e755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/505460">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d69982e764 class=n-a></a>Suttorp-Schulten MS, Rothova A: The possible impact of uveitis in blindness: a literature survey. <i>Br J Ophthalmol.</i> 1996; <b>80</b>(9): 8448. <a target=xrefwindow id=d69982e772 href="http://www.ncbi.nlm.nih.gov/pubmed/8962842">PubMed Abstract </a> | <a target=xrefwindow id=d69982e775 href="http://dx.doi.org/10.1136/bjo.80.9.844">Publisher Full Text </a> | <a target=xrefwindow id=d69982e778 href="http://www.ncbi.nlm.nih.gov/pmc/articles/505625">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d69982e787 class=n-a></a>Chang JH, Wakefield D: Uveitis: a global perspective. <i>Ocul Immunol Inflamm.</i> 2002; <b>10</b>(4): 26379. <a target=xrefwindow id=d69982e795 href="http://www.ncbi.nlm.nih.gov/pubmed/12854035">PubMed Abstract </a> | <a target=xrefwindow id=d69982e798 href="http://dx.doi.org/10.1076/ocii.10.4.263.15592">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725719555"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e807 class=n-a></a>Merida S, Palacios E, Navea A, <i> et al.</i>: New Immunosuppressive Therapies in Uveitis Treatment. <i>Int J Mol Sci.</i> 2015; <b>16</b>(8): 1877895. <a target=xrefwindow id=d69982e818 href="http://www.ncbi.nlm.nih.gov/pubmed/26270662">PubMed Abstract </a> | <a target=xrefwindow id=d69982e821 href="http://dx.doi.org/10.3390/ijms160818778">Publisher Full Text </a> | <a target=xrefwindow id=d69982e825 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4581271">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725719555">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718215532"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e838 class=n-a></a>Levy-Clarke G, Jabs DA, Read RW, <i> et al.</i>: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. <i>Ophthalmology.</i> 2014; <b>121</b>(3): 78596.e3. <a target=xrefwindow id=d69982e849 href="http://www.ncbi.nlm.nih.gov/pubmed/24359625">PubMed Abstract </a> | <a target=xrefwindow id=d69982e852 href="http://dx.doi.org/10.1016/j.ophtha.2013.09.048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718215532">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d69982e866 class=n-a></a>Schwartzman S, Schwartzman M: The Use of Biologic Therapies in Uveitis. <i>Clin Rev Allergy Immunol.</i> 2015; <b>49</b>(3): 30716. <a target=xrefwindow id=d69982e874 href="http://www.ncbi.nlm.nih.gov/pubmed/25431348">PubMed Abstract </a> | <a target=xrefwindow id=d69982e877 href="http://dx.doi.org/10.1007/s12016-014-8455-6">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726717192"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e886 class=n-a></a>Jaffe GJ, Dick AD, Brezin AP, <i> et al.</i>: Adalimumab in Patients with Active Noninfectious Uveitis. <i>N Engl J Med.</i> 2016; <b>375</b>(10): 93243. <a target=xrefwindow id=d69982e897 href="http://www.ncbi.nlm.nih.gov/pubmed/27602665">PubMed Abstract </a> | <a target=xrefwindow id=d69982e900 href="http://dx.doi.org/10.1056/NEJMoa1509852">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726717192">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d69982e913 class=n-a></a>van Denderen JC, Visman IM, Nurmohamed MT, <i> et al.</i>: Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis. <i>J Rheumatol.</i> 2014; <b>41</b>(9): 18438. <a target=xrefwindow id=d69982e924 href="http://www.ncbi.nlm.nih.gov/pubmed/25086071">PubMed Abstract </a> | <a target=xrefwindow id=d69982e927 href="http://dx.doi.org/10.3899/jrheum.131289">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726815247"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e936 class=n-a></a>Cordero-Coma M, Calleja-Antolin S, Garzo-Garcia I, <i> et al.</i>: Adalimumab for Treatment of Noninfectious Uveitis: Immunogenicity and Clinical Relevance of Measuring Serum Drug Levels and Antidrug Antibodies. <i>Ophthalmology.</i> 2016; <b>123</b>(12): 261825. <a target=xrefwindow id=d69982e947 href="http://www.ncbi.nlm.nih.gov/pubmed/27692527">PubMed Abstract </a> | <a target=xrefwindow id=d69982e950 href="http://dx.doi.org/10.1016/j.ophtha.2016.08.025">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726815247">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725294023"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e963 class=n-a></a>Hamam RN, Barikian AW, Antonios RS, <i> et al.</i>: Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study. <i>Ocul Immunol Inflamm.</i> 2016; <b>24</b>(3): 31926. <a target=xrefwindow id=d69982e974 href="http://www.ncbi.nlm.nih.gov/pubmed/25549063">PubMed Abstract </a> | <a target=xrefwindow id=d69982e977 href="http://dx.doi.org/10.3109/09273948.2014.990041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725294023">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718479011"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e990 class=n-a></a>Calvo-Rio V, Blanco R, Beltran E, <i> et al.</i>: Anti-TNF- therapy in patients with refractory uveitis due to Behet's disease: a 1-year follow-up study of 124 patients. <i>Rheumatology (Oxford).</i> 2014; <b>53</b>(12): 222331. <a target=xrefwindow id=d69982e1001 href="http://www.ncbi.nlm.nih.gov/pubmed/24996907">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1004 href="http://dx.doi.org/10.1093/rheumatology/keu266">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718479011">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718460153"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1018 class=n-a></a>Takeuchi M, Kezuka T, Sugita S, <i> et al.</i>: Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behcets disease: a multicenter study. <i>Ophthalmology.</i> 2014; <b>121</b>(10): 187784. <a target=xrefwindow id=d69982e1029 href="http://www.ncbi.nlm.nih.gov/pubmed/24950593">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1032 href="http://dx.doi.org/10.1016/j.ophtha.2014.04.042">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718460153">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718102211"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1045 class=n-a></a>Kruh JN, Yang P, Suelves AM, <i> et al.</i>: Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up. <i>Ophthalmology.</i> 2014; <b>121</b>(1): 35864. <a target=xrefwindow id=d69982e1056 href="http://www.ncbi.nlm.nih.gov/pubmed/24011995">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1059 href="http://dx.doi.org/10.1016/j.ophtha.2013.07.019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718102211">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d69982e1072 class=n-a></a>Saeed MU, Raza SH, Goyal S, <i> et al.</i>: Etanercept in methotrexate-resistant JIA-related uveitis. <i>Semin Ophthalmol.</i> 2014; <b>29</b>(1): 13. <a target=xrefwindow id=d69982e1083 href="http://www.ncbi.nlm.nih.gov/pubmed/24175644">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1086 href="http://dx.doi.org/10.3109/08820538.2013.839802">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d69982e1095 class=n-a></a>Shealy DJ, Cai A, Staquet K, <i> et al.</i>: Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor . <i>MAbs.</i> 2010; <b>2</b>(4): 42839. <a target=xrefwindow id=d69982e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/20519961">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1109 href="http://dx.doi.org/10.4161/mabs.12304">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1113 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3180089">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718152028"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1122 class=n-a></a>Miserocchi E, Modorati G, Pontikaki I, <i> et al.</i>: Long-term treatment with golimumab for severe uveitis. <i>Ocul Immunol Inflamm.</i> 2014; <b>22</b>(2): 905. <a target=xrefwindow id=d69982e1133 href="http://www.ncbi.nlm.nih.gov/pubmed/24143896">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1136 href="http://dx.doi.org/10.3109/09273948.2013.844265">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718152028">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d69982e1149 class=n-a></a>Calvo-Rio V, de la Hera D, Blanco R, <i> et al.</i>: Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review. <i>Clin Exp Rheumatol.</i> 2014; <b>32</b>(6): 8648. <a target=xrefwindow id=d69982e1160 href="http://www.ncbi.nlm.nih.gov/pubmed/25288110">PubMed Abstract </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725335363"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1170 class=n-a></a>Letko E, Yeh S, Foster CS, <i> et al.</i>: Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy. <i>Ophthalmology.</i> 2015; <b>122</b>(5): 93948. <a target=xrefwindow id=d69982e1181 href="http://www.ncbi.nlm.nih.gov/pubmed/25638011">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1184 href="http://dx.doi.org/10.1016/j.ophtha.2014.12.033">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725335363">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d69982e1197 class=n-a></a>Papo M, Bielefeld P, Vallet H, <i> et al.</i>: Tocilizumab in severe and refractory non-infectious uveitis. <i>Clin Exp Rheumatol.</i> 2014; <b>32</b>(4 Suppl 84):S759. <a target=xrefwindow id=d69982e1208 href="http://www.ncbi.nlm.nih.gov/pubmed/25268663">PubMed Abstract </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d69982e1217 class=n-a></a>Mesquida M, Molins B, Llorenc V, <i> et al.</i>: Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema. <i>Ophthalmology.</i> 2014; <b>121</b>(12): 23806. <a target=xrefwindow id=d69982e1228 href="http://www.ncbi.nlm.nih.gov/pubmed/25204610">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1231 href="http://dx.doi.org/10.1016/j.ophtha.2014.06.050">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d69982e1240 class=n-a></a>Sehgal SN: Sirolimus: its discovery, biological properties, and mechanism of action. <i>Transplant Proc.</i> 2003; <b>35</b>(3 Suppl): 7S14S. <a target=xrefwindow id=d69982e1248 href="http://www.ncbi.nlm.nih.gov/pubmed/12742462">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1251 href="http://dx.doi.org/10.1016/S0041-1345(03)00211-2">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725880147"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1260 class=n-a></a>Agarwal A, Rajagopalan N, Hassan M, <i> et al.</i>: Sirolimus for Retinal and Uveitic Diseases. <i>Dev Ophthalmol.</i> 2016; <b>55</b>: 27681. <a target=xrefwindow id=d69982e1271 href="http://www.ncbi.nlm.nih.gov/pubmed/26501229">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1274 href="http://dx.doi.org/10.1159/000438951">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725880147">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d69982e1287 class=n-a></a>Pleyer U, Thurau SR: Sirolimus for the treatment of noninfectious uveitis. <i>Expert Opin Pharmacother.</i> 2016; <b>17</b>(1): 12735. <a target=xrefwindow id=d69982e1295 href="http://www.ncbi.nlm.nih.gov/pubmed/26606152">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1298 href="http://dx.doi.org/10.1517/14656566.2016.1124855">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725375010"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1308 class=n-a></a>Garcia-Geremias M, Carreo E, Epps SJ, <i> et al.</i>: Clinical outcomes of intravenous immunoglobulin therapy in refractory uveitis. <i>Int Ophthalmol.</i> 2015; <b>35</b>(2): 2815. <a target=xrefwindow id=d69982e1319 href="http://www.ncbi.nlm.nih.gov/pubmed/25708281">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1322 href="http://dx.doi.org/10.1007/s10792-015-0051-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725375010">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d69982e1335 class=n-a></a>Thompson JT: Cataract formation and other complications of intravitreal triamcinolone for macular edema. <i>Am J Ophthalmol.</i> 2006; <b>141</b>(4): 62937. <a target=xrefwindow id=d69982e1343 href="http://www.ncbi.nlm.nih.gov/pubmed/16564796">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1346 href="http://dx.doi.org/10.1016/j.ajo.2005.11.050">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718119011"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1355 class=n-a></a>Park UC, Park JH, Yu HG: Long-term outcome of intravitreal triamcinolone acetonide injection for the treatment of uveitis attacks in Behet disease. <i>Ocul Immunol Inflamm.</i> 2014; <b>22</b>(1): 2733. <a target=xrefwindow id=d69982e1363 href="http://www.ncbi.nlm.nih.gov/pubmed/24063666">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1366 href="http://dx.doi.org/10.3109/09273948.2013.829109">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718119011">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d69982e1379 class=n-a></a>Lowder C, Belfort R, Lightman S, <i> et al.</i>: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. <i>Arch Ophthalmol.</i> 2011; <b>129</b>(5): 54553. <a target=xrefwindow id=d69982e1390 href="http://www.ncbi.nlm.nih.gov/pubmed/21220619">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1393 href="http://dx.doi.org/10.1001/archophthalmol.2010.339">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d69982e1402 class=n-a></a>Zarranz-Ventura J, Carreo E, Johnston RL, <i> et al.</i>: Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. <i>Am J Ophthalmol.</i> 2014; <b>158</b>(6): 11361145.e5. <a target=xrefwindow id=d69982e1413 href="http://www.ncbi.nlm.nih.gov/pubmed/25217856">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1416 href="http://dx.doi.org/10.1016/j.ajo.2014.09.003">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d69982e1425 class=n-a></a>Tomkins-Netzer O, Taylor SR, Bar A, <i> et al.</i>: Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis. <i>Ophthalmology.</i> 2014; <b>121</b>(8): 164954. <a target=xrefwindow id=d69982e1436 href="http://www.ncbi.nlm.nih.gov/pubmed/24650556">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1439 href="http://dx.doi.org/10.1016/j.ophtha.2014.02.003">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718461506"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1449 class=n-a></a>Bratton ML, He YG, Weakley DR: Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis. <i>J AAPOS.</i> 2014; <b>18</b>(2): 1103. <a target=xrefwindow id=d69982e1457 href="http://www.ncbi.nlm.nih.gov/pubmed/24698604">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1460 href="http://dx.doi.org/10.1016/j.jaapos.2013.11.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718461506">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725688781"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1473 class=n-a></a>Sella R, Oray M, Friling R, <i> et al.</i>: Dexamethasone intravitreal implant (Ozurdex) for pediatric uveitis. <i>Graefes Arch Clin Exp Ophthalmol.</i> 2015; <b>253</b>(10): 177782. <a target=xrefwindow id=d69982e1484 href="http://www.ncbi.nlm.nih.gov/pubmed/26228441">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1487 href="http://dx.doi.org/10.1007/s00417-015-3124-x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725688781">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725875146"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1500 class=n-a></a>Tomkins-Netzer O, Talat L, Seguin-Greenstein S, <i> et al.</i>: Outcome of Treating Pediatric Uveitis With Dexamethasone Implants. <i>Am J Ophthalmol.</i> 2016; <b>161</b>: 1105.e12. <a target=xrefwindow id=d69982e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/26478217">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1514 href="http://dx.doi.org/10.1016/j.ajo.2015.09.036">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725875146">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725799283"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1527 class=n-a></a>Kempen JH, van Natta ML, Altaweel MM, <i> et al.</i>: Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. <i>Am J Ophthalmol.</i> 2015; <b>160</b>(6): 11331141.e9. <a target=xrefwindow id=d69982e1538 href="http://www.ncbi.nlm.nih.gov/pubmed/26386159">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1541 href="http://dx.doi.org/10.1016/j.ajo.2015.09.017">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1545 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4657141">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725799283">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725736398"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1558 class=n-a></a>Kempen JH, Altaweel MM, Drye LT, <i> et al.</i>: Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. <i>Ophthalmology.</i> 2015; <b>122</b>(10): 196775. <a target=xrefwindow id=d69982e1569 href="http://www.ncbi.nlm.nih.gov/pubmed/26298715">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1572 href="http://dx.doi.org/10.1016/j.ophtha.2015.06.042">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1576 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4581989">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725736398">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725746948"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1589 class=n-a></a>Kempen JH, Altaweel MM, Drye LT, <i> et al.</i>: Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study. <i>Ophthalmology.</i> 2015; <b>122</b>(10): 197686. <a target=xrefwindow id=d69982e1600 href="http://www.ncbi.nlm.nih.gov/pubmed/26298718">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1603 href="http://dx.doi.org/10.1016/j.ophtha.2015.06.043">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1607 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4581951">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725746948">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725854641"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1621 class=n-a></a>Cokun E, Celemler P, Kimyon G, <i> et al.</i>: Intravitreal Dexamethasone Implant for Treatment of Refractory Behet Posterior Uveitis: One-year Follow-up Results. <i>Ocul Immunol Inflamm.</i> 2015; <b>23</b>(6): 43743. <a target=xrefwindow id=d69982e1632 href="http://www.ncbi.nlm.nih.gov/pubmed/26470764">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1635 href="http://dx.doi.org/10.3109/09273948.2015.1042167">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725854641">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725891825"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1648 class=n-a></a>Burkholder BM, Moradi A, Thorne JE, <i> et al.</i>: The Dexamethasone Intravitreal Implant for Noninfectious Uveitis: Practice Patterns Among Uveitis Specialists. <i>Ocul Immunol Inflamm.</i> 2015; <b>23</b>(6): 44453. <a target=xrefwindow id=d69982e1659 href="http://www.ncbi.nlm.nih.gov/pubmed/26517764">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1662 href="http://dx.doi.org/10.3109/09273948.2015.1070180">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725891825">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726141395"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1675 class=n-a></a>Brady CJ, Villanti AC, Law HA, <i> et al.</i>: Corticosteroid implants for chronic non-infectious uveitis. <i>Cochrane Database Syst Rev.</i> 2016; <b>2</b>: CD010469. <a target=xrefwindow id=d69982e1686 href="http://www.ncbi.nlm.nih.gov/pubmed/26866343">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1689 href="http://dx.doi.org/10.1002/14651858.CD010469.pub2">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5038923">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726141395">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d69982e1706 class=n-a></a>Wong IY, Koizumi H, Lai WW: Enhanced depth imaging optical coherence tomography. <i>Ophthalmic Surg Lasers Imaging.</i> 2011; <b>42 Suppl</b>: S7584. <a target=xrefwindow id=d69982e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/21790115">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1717 href="http://dx.doi.org/10.3928/15428877-20110627-07">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d69982e1726 class=n-a></a>Onal S, Tugal-Tutkun I, Neri P, <i> et al.</i>: Optical coherence tomography imaging in uveitis. <i>Int Ophthalmol.</i> 2014; <b>34</b>(2): 40135. <a target=xrefwindow id=d69982e1737 href="http://www.ncbi.nlm.nih.gov/pubmed/23835664">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1740 href="http://dx.doi.org/10.1007/s10792-013-9822-7">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726045063"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1749 class=n-a></a>Yan H, Li J, Zhang J, <i> et al.</i>: Retinal and Choroidal Thickness in Patients with Uveitis. <i>Ocul Immunol Inflamm.</i> 2015; 18. <a target=xrefwindow id=d69982e1757 href="http://www.ncbi.nlm.nih.gov/pubmed/26713716">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1760 href="http://dx.doi.org/10.3109/09273948.2015.1087576">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726045063">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718776353"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1774 class=n-a></a>Ghl Z, Kulcsr K, Kiss HJ, <i> et al.</i>: Retinal and choroidal thickness measurements using spectral domain optical coherence tomography in anterior and intermediate uveitis. <i>BMC Ophthalmol.</i> 2014; <b>14</b>: 103. <a target=xrefwindow id=d69982e1785 href="http://www.ncbi.nlm.nih.gov/pubmed/25176513 ">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1788 href="http://dx.doi.org/10.1186/1471-2415-14-103">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4236668">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718776353">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725424710"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1805 class=n-a></a>Sharma S, Lowder CY, Vasanji A, <i> et al.</i>: Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography. <i>Ophthalmology.</i> 2015; <b>122</b>(7): 146470. <a target=xrefwindow id=d69982e1816 href="http://www.ncbi.nlm.nih.gov/pubmed/25846846">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1819 href="http://dx.doi.org/10.1016/j.ophtha.2015.02.032">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725424710">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718391878"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1832 class=n-a></a>Keane PA, Karampelas M, Sim DA, <i> et al.</i>: Objective measurement of vitreous inflammation using optical coherence tomography. <i>Ophthalmology.</i> 2014; <b>121</b>(9): 170614. <a target=xrefwindow id=d69982e1843 href="http://www.ncbi.nlm.nih.gov/pubmed/24835759">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1846 href="http://dx.doi.org/10.1016/j.ophtha.2014.03.006">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4507470">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718391878">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725855247"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1863 class=n-a></a>Zarranz-Ventura J, Keane PA, Sim DA, <i> et al.</i>: Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy. <i>Am J Ophthalmol.</i> 2016; <b>161</b>: 17280.e14. <a target=xrefwindow id=d69982e1874 href="http://www.ncbi.nlm.nih.gov/pubmed/26476212">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1877 href="http://dx.doi.org/10.1016/j.ajo.2015.10.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725855247">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726338107"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1890 class=n-a></a>Sreekantam S, Macdonald T, Keane PA, <i> et al.</i>: Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenons triamcinolone acetonide for uveitic cystoid macular oedema. <i>Br J Ophthalmol.</i> 2017; <b>101</b>(2): 1759. <a target=xrefwindow id=d69982e1901 href="http://www.ncbi.nlm.nih.gov/pubmed/27150826">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1904 href="http://dx.doi.org/10.1136/bjophthalmol-2015-308008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726338107">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727372179"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1917 class=n-a></a>Shoughy SS, Arevalo JF, Kozak I: Update on wide- and ultra-widefield retinal imaging. <i>Indian J Ophthalmol.</i> 2015; <b>63</b>(7): 57581. <a target=xrefwindow id=d69982e1925 href="http://www.ncbi.nlm.nih.gov/pubmed/26458474">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1928 href="http://dx.doi.org/10.4103/0301-4738.167122">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4652247">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727372179">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725366649"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1945 class=n-a></a>Karampelas M, Sim DA, Chu C, <i> et al.</i>: Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. <i>Am J Ophthalmol.</i> 2015; <b>159</b>(6): 11611168.e1. <a target=xrefwindow id=d69982e1956 href="http://www.ncbi.nlm.nih.gov/pubmed/25709064">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1959 href="http://dx.doi.org/10.1016/j.ajo.2015.02.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725366649">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725409590"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d69982e1972 class=n-a></a>Chi Y, Guo C, Peng Y, <i> et al.</i>: A prospective, observational study on the application of ultra-wide-field angiography in the evaluation and management of patients with anterior uveitis. <i>PLoS One.</i> 2015; <b>10</b>(3): e0122749. <a target=xrefwindow id=d69982e1983 href="http://www.ncbi.nlm.nih.gov/pubmed/25815841">PubMed Abstract </a> | <a target=xrefwindow id=d69982e1986 href="http://dx.doi.org/10.1371/journal.pone.0122749">Publisher Full Text </a> | <a target=xrefwindow id=d69982e1990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4376869">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725409590">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 16 Mar 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-280&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-280&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan<br/> <sup>2</sup> School of Medicine, National Yang-Ming University, Taipei, Taiwan<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-280/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 16 Mar 2017, 6:280 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10587.1">https://doi.org/10.12688/f1000research.10587.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Chen SC and Sheu SJ. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11409 data-id=10587 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10587.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-280/v1/pdf?article_uuid=a1134dfe-f7d7-4836-a99f-47ebaa864b51" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10587.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Chen SC and Sheu SJ. Recent advances in managing and understanding uveitis [version 1; peer review: 3 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):280 (<a href="https://doi.org/10.12688/f1000research.10587.1" target=_blank>https://doi.org/10.12688/f1000research.10587.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10587 id=mobile-track-article-signin-10587 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10587?target=/articles/6-280"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11409 /> <input name=articleId type=hidden value=10587 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Carlos Pavesio</strong>, Moorfields Eye Hospital, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>C Stephen Foster</strong>, Massachusetts Eye Research and Surgery Institution (MERSI), USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Peter McCluskey</strong>, University of Sydney, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 16 Mar 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-280&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-280&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21075-20793></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21073-20795></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21077-20796></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-280/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>16 Mar 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Carlos Pavesio</strong>, Moorfields Eye Hospital, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>C Stephen Foster</strong>, Massachusetts Eye Research and Surgery Institution (MERSI), USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Peter McCluskey</strong>, University of Sydney, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-280&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-280/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in managing and understanding...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-280/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-280/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-280/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Chen SC and Sheu SJ');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-280/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-280",
            templates : {
                twitter : "Recent advances in managing and understanding uveitis. Chen SC and Sheu SJ, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-280/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in managing and understanding uveitis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in managing and understanding uveitis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10587/11409")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11409");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "20793": 0,
                           "20795": 0,
                           "20796": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "1c420fdf-f8ae-4eb2-b7aa-be6ca77de362";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-280.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-280.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-280.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-280.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-280.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>